March 03, 2015 12:52 AM ET

Biotechnology

Company Overview of TcLand Expression SA

Company Overview

TcLand Expression SA engages in the development of gene expression biomarkers for unmet medical needs in transplantation and auto-immune diseases. The company’s biomarkers include K score, a non invasive composite test to identify the kidney graft recipients who reduce their immunosuppressive treatment without rejecting their graft, with a high risk of rejection, and require an adjusted treatment, as well as to identify the early risk of rejection in just-grafted patients. Its biomarkers also include K-TolX for immunosuppressant in transplantation research; K-RejX, a set of genes dedicated to identify chronic rejection in kidney graft recipients at distance of the graft; and T cell repertoir...

Halle 13

Bio-Ouest Ile de Nantes

21 Rue de la Noue Bras de Fer

Nantes,  44200

France

Founded in 2002

Phone:

33 2 40 35 89 99

Fax:

33 2 40 35 67 20

Key Executives for TcLand Expression SA

Co-Founder, Chief Executive Officer and Director
Age: 51
Co-Founder and Director
Director of Corporate & Business Development and Licensing
Quality Assurance Manager
Vice President of Sales & Service Operations
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Genolife SA Europe
EyeGate Pharma S.A.S. Europe
MABLife SAS Europe
Biocortech Europe
GIE LABORATOIRE D'ANALYSES GENETIQUES POUR LES ESPECES ANIMALES Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TcLand Expression SA, please visit www.tcland-biotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.